🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › Indiana › Hammond

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Hammond, IN

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Hammond. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Nagre-recruitPhase 3
  • The Community Hospital, Munster · 1 mi ang layo
  • Women's Diagnostic Center - Munster, Munster · 1 mi ang layo
  • Northwest Oncology LLC, Dyer · 6 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3
  • The Community Hospital, Munster · 1 mi ang layo
  • Women's Diagnostic Center - Munster, Munster · 1 mi ang layo
  • Northwest Oncology LLC, Dyer · 6 mi ang layo
  • at 2 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Nagre-recruitPhase 3
  • Northwest Cancer Centers, P.C., Dyer · 6 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07361510

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 2
  • Franciscan Health, Munster · 1 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07154290

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1
  • Ingalls Family Care Center, Calumet City · 3 mi ang layo
  • UChicago Medicine Ingalls Memorial, Harvey · 8 mi ang layo
  • UChicago Medicine at Ingalls - Flossmoor, Flossmoor · 10 mi ang layo
  • at 1 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • Advocate South Suburban Hospital, Hazel Crest · 10 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2
  • Advocate South Suburban Hospital, Hazel Crest · 10 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3
  • Advocate South Suburban Hospital, Hazel Crest · 10 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Nagre-recruitPhase 1/2
  • Northwest Cancer Centers, Dyer · 6 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT06244771

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral
  • Advocate South Suburban Hospital, Hazel Crest · 10 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Hammond

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.